Announcing Benchling for Lab Automation: Harness the full power of your lab hardware Learn More

Meet our customers

“Since our founding, science has remained our central guiding principle. Benchling fits perfectly into this philosophy, providing us a flexible informatics platform that enables our scientists to focus on high-impact research and deliver life-transforming medicines.”
Nicholas Papadopoulos SVP R&D Operations, Regeneron

More than 215,000 scientists worldwide across pharma, biotech, and academia

  • Pfizer

    One of the world's largest pharmaceutical companies developing cutting-edge drugs in immunology, oncology, cardiology, and more.
  • Regeneron

    A leading biotechnology company using the power of science to bring new medicines to patients in need.
  • Zoetis

    Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways, delivering medicines, vaccines, and diagnostic products.
  • Ginkgo

    Ginkgo Bioworks is designing custom organisms for customers across multiple markets, learning from nature to replace technology with biology.
  • Mammoth Biosciences

    Mammoth Biosciences provides a CRISPR-based platform for disease detection across healthcare, agriculture, and other industries
  • Daiichi Sankyo Inc

    Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan.
  • Eisai

    Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.
  • BEAM Therapeutics

    Beam is pioneering the use of base editing — a potential new class of precision genetic medicines — with a vision of providing life-long cures to patients suffering from serious diseases.
  • BP Biosciences

    BP’s Biosciences Center conducts innovative research, supports strategic investments and manages academic partnerships designed to accelerate the global transition to a low-carbon future.
  • Arsenal Biosciences

    ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies.
  • Rubius

    Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines.
    Case Study
  • Kite Pharma

    Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer.
  • Zymergen

    Unlocking the power of biology to make strain optimization as reliable and predictable as other engineering processes.
    Case Study
  • Spotlight Therapeutics

    We are creating next-generation programmable nucleases that can selectively edit specific cell populations directly in the body.
  • Kyverna Therapeutics

    Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
  • Pairwise

    Pairwise is bringing together leaders in agriculture and technology to harness the potential of genome editing to address consumers’ and farmers’ needs.
  • Editas

    A leading genome editing company dedicated to treating patients with genetically defined diseases.
  • Insitro

    insitro will integrate cutting-edge machine learning techniques with the innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets.
  • Bolt Threads

    Bolt Threads is bioengineering the next generation of fabrics and garments with their Microsilk and Mylo technologies.
  • Denali Therapeutics

    Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
  • Sorrento

    Sorrento Therapeutics is a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possible curable diseases.
  • Lyell Immunopharma

    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality.
  • Sana Biotechnology

    Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease.
  • Synlogic

    Synlogic is working at the cross section of biology and engineering, advancing a new class of medicines for patients.
    Case Study
  • Adicet Bio

    Universal, off-the-shelf immune cell therapy for treatment of cancer and other diseases
    Case Study
  • Ligand Pharmaceuticals

    Ligand has one of the largest and most diverse portfolios in the pharmaceutical industry. Currently approved portfolio drugs include those that treat cancer, osteoporosis, and fungal infections.
  • Arcturus Therapeutics

    An industry leader in the application of RNA technologies for the treatment of disease and improved quality of life.
    Case Study
  • Caribou Biosciences

    Advancing new applications for CRISPR-Cas gene editing to help bring the promise this technology holds for patients and consumers to reality.
  • New England Biolabs

    Recombinant and native enzyme reagents for life science research. Provides solutions supporting genome editing, synthetic biology and next-generation sequencing.
  • Agenus

    Using the power of the immune system to develop a broad range of innovative therapeutic antibody and vaccine candidates against cancer.
    Case Study
  • Dragonfly Therapeutics

    Developing novel first-in-class therapeutics targeted at Natural Killer cells and other cells of the innate immune system.
  • eGenesis

    Making xenotransplantation a routine medical procedure for the delivery of safe & effective human transplantable cells, tissues & organs.
  • IGM Biosciences

    IGM is pioneering the development of the IgM class of antibodies as therapeutic treatments for human disease.
  • Invaio Sciences

    Invaio Sciences is a transformative early-stage startup developing a platform to control the fitness and behavior of pests and target insects in a targeted, sustainable, and natural way.
  • Kymera Therapeutics

    Kymera Therapeutics is pioneering a new therapeutic modality and platform to transform drug discovery and deliver breakthrough medicines for previously untreatable diseases.
  • Tenaya Therapeutics

    Tenaya is addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle.
  • TScan Therapeutics

    TScan is harnessing novel T cell systems to extend the promise of immunotherapy.
  • Arcus Biosciences

    Arcus is utilizing its small molecule discovery and development capabilities to create innovative cancer immunotherapies.
  • Bioverativ

    Bioverativ Inc. is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.
  • Surrozen

    Surrozen is discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.
  • Adimab

    A premier human antibody discovery and optimization platform defined by speed, diversity, and quality.
  • Antheia

    Providing a stable and cost-competitive supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines.
  • Atreca

    Atreca focuses on the immune responses of patients to discover and develop novel immunotherapies.
  • Cedilla Therapeutics

    Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics to work on diseases caused by protein dysregulation.
  • Cue Biopharma

    Cue Biopharma is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system.
  • CytomX

    CytomX is a clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer.
  • Harpoon Therapeutics

    Leveraging a platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases
  • Hibercell

    HiberCell is developing first-in-class therapeutics that target dormant disseminated tumor cells from solid and liquid cancers to the prevent or delay the recurrence of cancer.
  • Lung Biotechnology

    Lung Biotechnology's mission is to simplify and democratize the treatment of lung disease, using biotechnology to design therapies for PAH and other fatal lung diseases.
  • Recursion Pharmaceuticals

    Discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers.
  • Senti Biosciences

    Leveraging expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
  • Translate Bio

    Translate Bio is an mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
  • uniQure

    Delivering on the promise of gene therapy, single treatments with potentially curative results.
  • Xencor

    Expanding the therapeutic boundaries of monoclonal antibody drugs with its XmAb antibody engineering platform.
  • Arbor Biotechnologies

    We have built a next-generation biodiscovery platform to uncover novel CRISPR enzymes and systems that can power transformative applications across a range of industries.
  • Arch Oncology

    At Arch Oncology, we are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer.
  • Arvinas

    At Arvinas, we’re leading the creation of an entirely new way to treat disease through therapies that target and degrade disease-related proteins.
  • Cogen Therapeutics

    Cogen Therapeutics develops immune modulation therapeutics that control the immune system, targeting the specific drivers of disease.
  • Sound Agriculture

    Sound Agriculture, formerly known as Asilomar Bio, is developing technologies to help growers sustainably increase productivity by enhancing crop nutrient and water use.
  • Synbal

    Synbal, Inc. is using its proprietary next-generation gene-editing platform, Active Genetics, to develop safer, non-viral, cell-based gene therapy candidates.
  • Alector

    Our mission is to eliminate neurodegeneration through immuno-neurology. This is a therapeutic approach that harnesses the body's own immune system to combat these devastating diseases.
  • ABL Bio

    ABL Bio is one of the world's leading biotech research companies focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases.
  • Carisma Therapeutics

    Carisma Therapeutics is pioneering CAR macrophage immunotherapy to target solid tumors.
  • Cygnal Therapeutics

    Cygnal Therapeutics is developing drugs to manipulate exoneural biology for the treatment of cancer, immunological diseases, and regenerative processes.
  • Eligo Bioscience

    Developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome.
  • Inari

    Developing and delivering innovative therapies that harness the human gut microbiome.
  • Incyte

    Investigating the immune-suppressive tumor microenvironment through both small and large molecule approaches that target diverse mechanisms.
  • Maverick Therapeutics

    Redirected T cell therapeutics designed to deliver potent activity with increased tumor specificity and reduced toxicity.
  • Obsidian Therapeutics

    Building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients.
  • Orum

    Developing next-generation therapeutic antibodies to directly target cytosolic proteins associated with many human diseases that have been previously considered untreatable.
  • Pandion Therapeutics

    Shifting the paradigm from systemic immunosuppression to localized immunomodulation with the next generation of targeted therapeutics.
  • Verseau

    Transforming immunotherapy.
  • Voyager Therapeutics

    Developing life-changing gene therapies with a focus on severe neurological diseases that lack safe and effective treatment options.
  • Amunix

    Amunix is leveraging our expertise in precision protein engineering to enable the promise of T cell engagers in solid tumors.
  • CERo Therapeutics

    CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
  • Chimera Bioengineering

    We’re unlocking the complexities of the immune system to develop highly effective, precisely targeted therapies for cancer and autoimmune diseases.
  • Compass Therapeutics

    We’re unlocking the complexities of the immune system to develop highly effective, precisely targeted therapies for cancer and autoimmune diseases
  • D2G Oncology

    D2G Oncology relates drugs to genotypes to transform precision cancer therapeutics.
  • Dyno Therapeutics

    Dyno Therapeutics is leading a machine learning revolution to develop technologies that dramatically enhance new therapies for genetic disease.
  • Glympse Bio

    We are pioneering the development of synthetic biomarkers that are bioengineered to be perfectly tunable to any disease, absolutely specific, and offer earlier measures of response.
  • Locus Biosciences

    We are an emerging biotechnology company that develops precision antibacterial products.
  • Oncomyx

    OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer.
  • Ring Therapeutics

    We are developing Anellovectors™, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome
  • Soteria Biotherapeutics

    We are developing next-generation immunotherapies with improved efficacy and safety. 
  • Strand Therapeutics

    Strand is increasing mRNA therapy safety and efficacy by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body using mRNA-encoded logic circuits.
  • enGene Incorporated

    enGene has developed a robust non-viral gene-therapy platform to transport DNA sequences across mucosal barriers.
  • Ribometrix

    Discovering small molecule drugs that target functional 3D RNA structures to treat human diseases.
  • Asimov

    Asimov strives to enable biotechnologies with global benefit by combining synthetic biology and computer science.
  • Finch

    Developing and delivering innovative therapies that harness the human gut microbiome.
  • Freenome

    Making cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science.
  • Horizon

    A leading gene editing company that designs and engineers genetically modified cells for clinical applications.
  • Inhibrx

    Enabling fit-for-function biotherapeutics that optimally interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling.
  • Jnana Therapeutics

    Jnana is pushing the frontiers of knowledge and technology to decipher the language of cellular metabolite communication and unlock SLC transporters as a therapeutic target class.
  • LogicBio Therapeutics

    Harnessing the body's natural DNA repair process to provide precise, stable, and durable therapies to patients with serious genetic diseases.
  • Lumen Bioscience

    Lumen Bioscience makes oral antibody therapeutics.
  • MiNA Therapeutics

    Harnessing the innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’' cells.
  • Neucyte

    NeuCyte is an innovative biotechnology company focused on CNS drug discovery. NeuCyte has developed an in vitro platform for neurotoxicity assessment, disease modeling, and more.
  • Synpromics

    Improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design.
  • 3T Biosciences

    3T Biosciences is solving a major bottleneck in the field of immunotherapy – identifying novel targets that can be used to generate therapies to treat cancer in broad patient populations.
  • Aralez Bio

    Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.
  • Engine Biosciences

    Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine.
  • GO Therapeutics

    GO Therapeutics is developing a range of cancer drug candidates that are exquisitely tumor specific.
  • GPCR Therapeutics

    GPCR Therapeutics, Inc. is developing pharmaceuticals based on the cutting-edge knowledge of G Protein-Coupled Receptors (GPCRs).
  • Kintai Therapeutics

    We leverage the body’s robust signaling networks to pioneer PEM™ compounds, a new class of precision-based orally available small molecule therapeutics to restore health and fight disease.
  • Lygos

    Lygos employs cutting edge synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals.
  • NovoNutrients

    NovoNutrients transforms waste industrial CO2 into feed, through industrial biotech, initially for the fast-growing aquaculture sector.
  • RootPath Genomics

    RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy.
  • TCRCure Biopharma

    TCRCure possesses streamlined biotechnology development including vector and cell manufacturing, which enables clinical translation intended for full-fledged immunotherapy services
  • TripleBar Bio

    We see a future where biotechnology improves the sustainability of food supply production, processing, and packaging.
  • Y Biologics

    Since its foundation, we have dedicated ourselves to the discovery & development of novel antibody therapeutics.
  • AgBiome

    AgBiome develops innovative, cutting-edge solutions using new knowledge of the plant-associated microbiome to create novel products.
  • enEvolv

    Engineering microorganisms to produce valuable bio-based products from renewable feedstocks.
  • EnginZyme

    EnginZyme engineers cost-competitive biocatalytic solutions fast than ever before, using their universal system for enzyme immobilization.
  • Genus

    Investigating the application of novel gene editing technologies towards bovine genetics.
  • Abvance

    We are a science-driven biopharmaceutical start-up on a mission to deliver innovative antibody-based medicines for the treatment of immune disorders and inflammatory diseases.
  • Federation Bio

    The Future of the Microbiome - Harnessing the power of defined complex microbial communities to provide a robust and lasting cure for high unmet need diseases
  • Good Therapeutics

    Good Therapeutics is  developing "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity.
  • Gordian Biotechnology

    Gordian is extending the reach of gene therapy to diseases of aging via a novel screening platform.
  • MacrophOx

    MacrophOx is pioneering sophisticated genetic, immunological and cell biological solutions to the major challenges that currently limit cell therapy for cancer.
  • NAVAN Technologies

    NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human primary cells.
  • PetMedix

    PetMedix is using the highest quality science to make the medicines our pets need and deserve, keeping them healthier, happier, and for longer.
  • Specifica

    Specifica creates antibody libraries in single chain Fv or Fab formats, in phage or yeast display platforms, and based on natural or synthetic sources.
  • Akrevia Therapeutics

    Akrevia Therapeutics is focused on developing highly potent, tumor-targeted immuno-oncology therapeutics.
  • Aether Biomachines

    Aether Biomachines is repurposing enzymes to reinvent previously discovered compounds and create novel compounds.
  • GeneQuine Biotherapeutics

    GeneQuine Biotherapeutics GmbH develops novel therapies for osteoarthritis, a degenerative joint disease with high unmet medical need.
  • Lucira Health

    We are revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing tools to empower people to become knowledgeable about their health.
  • Hexagon Bio

    Mining massive amounts of genomic data from fungal genomes to identify novel drugs for diseases with unmet needs.
  • Rarecyte

    RareCyte is enabling next-generation analysis of rare cells with an open and end-to-end platform that supports clinical trials worldwide.
  • Antel Biosystems (CentralStar Cooperative)

    AntelBio is a leader in the development and application of innovative diagnostic solutions for the animal industry.
  • Apic Bio

    Apic Bio is committed to finding cures for patients with genetic diseases and is currently developing best-in-class treatment options for rare, devastating neurological and liver diseases.
  • Axitan

    Axitan has established a robust platform to engineer and grow microalgae in a cost effective and sustainable manner.
  • Biosyntia

    Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
  • CB Therapeutics

    We Are Advancing Fermentation-based Cellular Agriculture to Produce Natural Molecules with Greater Purity, Consistency and Efficiency
  • Edi-Gene

    EdiGene is translating cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to advance drug discovery.
  • GigaGen

    GigaGen develops novel antibody therapies for patients with diseases that result from immune system dysregulation including cancer and immune deficiencies.
  • Hunterian Medicine

    Hunterian Medicine is a gene editing company poised to unleash the full potential of CRISPR.
  • Hyasynth Bio

    Our specialty is in producing natural molecules, derivatives, and new targets using a fast and scalable platform based on engineered microbes.
  • Immunai Inc.

    ImmunAI provides a platform that combines biology with machine-learning to unravel the immune system.
  • Persona Biome

    Persona Biome is dedicated to finding the health we have lost — starting with your skin.
  • Admirx

    Admirx is a preclinical-stage company developing anti-complement therapies to treat life threatening auto-immune and inflammatory diseases.
  • Samplix

    Samplix is a biotechnology company that has developed a proprietary technology for single molecule sample preparation.
  • Scenic Biotech

    Scenic is pioneering genetic modifies for drug discovery to build a pipeline of breakthrough products.
  • A-Alpha Bio

    We are a team of synthetic biologists and next-generation sequencing experts focused on disrupting the way that pharmaceutical companies discover, optimize, and characterize drugs.
  • Alkahest

    Alkahest is targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease.
  • Amyloid Solution

    Amyloid Solution seeks to overcome Alzheimer's Disease by developing innovative disease-modifying treatments that address different stages of patients during the course of disease progression.
  • Aromyx Corporation

    Aromyx uses the biological receptors from the human nose to create quantitative representations of sensory data for multiple applications.
  • Azitra

    Azitra Inc. is leveraging extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.
  • Creatus Biosciences

    Creatus is developing one of the most attractive mixed-sugar biorefinery platforms in the industry
  • DefiniGEN

    DefiniGEN are a Cambridge UK company providing highly functional disease model human cells including hepatocytes, pancreatic beta cells and intestinal organoids.
  • Diadem Biotherapeutics

    Diadem Biotherapeutics is pioneering the development of first-in-class engineered exosomes to treat chronic inflammatory and auto-immune conditions.
  • Empyrean Therapeutics

    Empyrean Therapeutics is focused on developing next generation cell therapies to enable global and affordable cures for disease.
  • ExpreS2ion Biotechnologies

    We are a team of highly experienced scientists specialised in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system.
  • GABAeron

    GABAeron focuses on engineered stem cell lines, genetic data and small-molecule drugs in hopes of developing therapeutics to preserve and maybe restore brain function in Alzheimer’s.
  • Industrial Microbes

    We upgrade methan to chemicals using synthetic biology.
  • Leveragen

    Leveragen is a Boston-based biotech startup company providing customized genetic modeling services.
  • Life Foundry

    With synthetic biology and fully automated bio-manufacturing, we enable industrialized, on-demand, high-throughput, and flexible engineering of biological systems for practical applications.
  • Membio

    Membio is on a mission to ensure the world has a safe and sufficient supply of blood.
  • NemaMetrix

    NemaMetrix Inc. is a biotechnology company that develops solutions and commercializes proprietary systems for the genetic modification of simple microscopic living animals.
  • Nucleo Life Sciences

    Based in the San Francisco Bay Area, Nucleo Life Sciences is a boutique CMO that’s passionate about helping you take your drugs into the clinic—and the market—as quickly and effectively as humanly possible.
  • Olema Pharmaceuticals

    Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer.
  • OneSkin Technologies

    Our mission is to be the company you can trust to keep you young while you age.
  • Phenomic AI

    We’re leveraging computer vision and high-content screening to develop the next wave of therapeutic antibodies against cancer and fibrosis.
  • Redbiotec

    With a proven track record in biopharmaceuticals, we aim to revolutionize advanced gene therapy to address unmet patient needs.
  • SNIPR Biome

    Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
  • SyntheX

    We are harnessing evolution in our synthetic biology based selection platforms to create and identify molecules that disrupt or bridge previously 'undruggable' protein-protein interactions.
  • T2 Biosystems

    At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster.
  • Valitor

    We are developing a new generation of biotechnology drugs that act precisely within a targeted diseased tissue.
  • Vectron Biosolutions AS

    Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins.
  • Xenocells

    We are interested in changing the status quo by systematizing BIOLOGIC units and constructing modular composition rules.
  • Abalone Bio

    Abalone is shifting the paradigm for antibody development, isolating drug candidates directly by their modulating effects on integral membrane proteins.
  • Anwita Bio

    Anwita Biosciences is a San Francisco Bay Area startup company specializing in antibodies and fusion proteins for therapies in oncology and auto-immune disease.
  • B-MoGen Biotechnologies

    We focus on complex genome engineering providing proprietary, cutting edge gene delivery and editing tools to enable faster research and cost effective therapies.
  • Bio-Meme

    Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.
  • BioPlx Microbiomics

    BioPlx is an advanced microbiomics company developing non-antibiotic methods for the control of infectious disease, including multiple-drug resistant "super-bugs".
  • Quintara Bio

    Quintara Biosciences specializes in providing high quality DNA sequencing and genomic services for life science research communities around the globe.
  • Seer Biosciences

    Seer is extracting deep molecular insights from the proteome to enable early detection of cancer and neurological diseases, drive earlier treatment, and improve patient outcomes.
  • Zymochem

    Our mission is to develop microbes & bioprocesses that enable profitable and eco-friendly production of chemicals from renewable sources such as sugars.

Join over 215,000 scientists using
Benchling to power life science R&D